Carvedilol reduces the costs of medical care in severe heart failure: An economic analysis of the COPERNICUS study applied to the United Kingdom
- 8 April 2005
- journal article
- Published by Elsevier in International Journal of Cardiology
- Vol. 100 (1), 143-149
- https://doi.org/10.1016/j.ijcard.2004.12.003
Abstract
No abstract availableKeywords
This publication has 20 references indexed in Scilit:
- Congestive heart failure in Latin America: the next epidemicAmerican Heart Journal, 2004
- Prevalence of self-reported heart failure among US adults: results from the 1999 National Health Interview SurveyAmerican Heart Journal, 2003
- Heart failure and the aging population: an increasing burden in the 21st century?Heart, 2003
- Angiotensin converting enzyme inhibition and hospitalisation rates for heart failure in the Netherlands, 1980 to 1999: the end of an epidemic?Heart, 2002
- More ‘malignant’ than cancer? Five‐year survival following a first admission for heart failureEuropean Journal of Heart Failure, 2001
- Trends in hospitalization for heart failure in Scotland, 1990–1996. An epidemic that has reached its peak?European Heart Journal, 2001
- Evidence of Improving Prognosis in Heart FailureCirculation, 2000
- Survival of patients with a new diagnosis of heart failure: a population based studyHeart, 2000
- Hospitalization of patients with heart failure: National Hospital Discharge Survey, 1985 to 1995American Heart Journal, 1999
- Effects of ACE Inhibitors on Heart Failure in The NetherlandsPharmacoEconomics, 1993